Spero Therapeutics
- Pharmaceutical Preparations
- Cambridge, Massachusetts
Compensation history
Top executives at Spero Therapeutics received an average of $2M per person in annual compensation from 2016 to 2022.
By year
Executives
We found seven executives who work or worked at Spero Therapeutics.
Ankit Mahadevia
Spero Therapeutics
Chief Executive Officer
Satyavrat Shukla
Spero Therapeutics
Chief Executive Officer
Tamara Joseph
Spero Therapeutics
Chief Legal Officer
Cristina Larkin
Spero Therapeutics
Chief Operating Officer
Christina Larkin
Spero Therapeutics
Chief Operating Officer
David Melnick
Spero Therapeutics
Chief Medical Officer
Joel Sendek
Spero Therapeutics
Chief Financial Officer
News
Spero Therapeutics CEO Ankit Mahadevia's 2022 pay slips 13% to $4.2M
September 1, 2023
Spero Therapeutics CEO Ankit Mahadevia's 2021 pay jumps 130% to $4.9M
August 5, 2022
Spero Therapeutics CEO Ankit Mahadevia's 2019 pay jumps 148% to $1.8M
September 30, 2020
Spero Therapeutics Chief Medical Officer David Melnick receives $1.6M in 2018
April 26, 2019
About Spero Therapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 675 Massachusetts Avenue, 14th Floor, Cambridge, Massachusetts 02139
- 857-242-1600
- December 31
- Former names
- Spero Therapeutics, LLC